Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 13, 2022

BUY
$30.71 - $45.71 $7.54 Million - $11.2 Million
245,500 Added 5455.56%
250,000 $8.28 Million
Q4 2021

Feb 14, 2022

BUY
$37.06 - $47.11 $166,770 - $211,995
4,500 New
4,500 $192,000
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $10.2 Million - $14.6 Million
-254,300 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$54.88 - $79.29 $8.23 Million - $11.9 Million
150,000 Added 143.82%
254,300 $14.4 Million
Q1 2021

May 17, 2021

BUY
$70.65 - $96.76 $1.6 Million - $2.19 Million
22,600 Added 27.66%
104,300 $7.81 Million
Q4 2020

Feb 12, 2021

BUY
$58.41 - $89.06 $140,184 - $213,744
2,400 Added 3.03%
81,700 $7.07 Million
Q3 2020

Nov 16, 2020

SELL
$41.13 - $62.45 $6.17 Million - $9.37 Million
-150,000 Reduced 65.42%
79,300 $4.85 Million
Q2 2020

Aug 14, 2020

BUY
$25.95 - $43.15 $1.95 Million - $3.24 Million
75,000 Added 48.61%
229,300 $9.53 Million
Q1 2020

May 15, 2020

BUY
$26.15 - $77.24 $4.03 Million - $11.9 Million
154,300 New
154,300 $4.43 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.